STOCK TITAN

MFS reports 12.45M-share, 6.0% stake in QGEN (NYSE: QGEN)

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Massachusetts Financial Services Company amended its Schedule 13G to report beneficial ownership of 12,447,526 shares of QIAGEN N.V. common stock, representing 6.0%. The filing states MFS has sole power to vote 11,469,431 shares and sole dispositive power over 12,447,526 shares. The amendment is signed by the Compliance Director on 06/05/2026.

Positive

  • None.

Negative

  • None.

Insights

Large passive holder reports a 6.0% stake and full dispositive control.

Massachusetts Financial Services Company reports beneficial ownership of 12,447,526 shares (6.0%), with 11,469,431 shares listed as sole voting power. This is an ownership disclosure under Schedule 13G/A, indicating institutional holdings rather than a transaction narrative.

Operationally, the filing documents MFS's voting and dispositive authority; timing and trading activity are not described. Subsequent filings would show changes to this position.

Beneficial ownership 12,447,526 shares reported on Schedule 13G/A
Percent of class 6.0% percent of common stock
Sole power to vote 11,469,431 shares shares with sole voting power
Sole dispositive power 12,447,526 shares shares with sole dispositive power
CUSIP N72482156 QIAGEN N.V. common stock identifier
Signature date 06/05/2026 date the amendment was signed
Schedule 13G/A regulatory
"Amendment No. 8 ) QIAGEN N.V. Common Stock"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
beneficially owned regulatory
"Amount beneficially owned: 12,447,526 shares of Common Stock"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole dispositive power regulatory
"Sole power to dispose or to direct the disposition of: 12,447,526"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
sole power to vote regulatory
"Sole power to vote or to direct the vote: 11,469,431"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does MFS report in QGEN?

MFS reports beneficial ownership of 12,447,526 shares, equal to 6.0% of QIAGEN N.V. common stock according to the amendment. This figure is the ownership amount disclosed in the Schedule 13G/A filing.

How many shares does MFS have voting control over in QGEN?

The filing states MFS has sole voting power over 11,469,431 shares of QIAGEN N.V. common stock. Shared voting power is reported as 0 in the amendment.

Does the Schedule 13G/A show MFS sold or bought QGEN shares?

The amendment discloses beneficial ownership levels and voting/dispositive power; it does not detail specific purchases or sales. The filing is a positional disclosure, not a transaction report.

When was the Schedule 13G/A amendment signed for QGEN?

The amendment is signed by the Compliance Director on 06/05/2026. The cover lists the CUSIP N72482156 and an internal date of 05/29/2026 related to the filing.





N72482156

(CUSIP Number)
05/29/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



Massachusetts Financial Services Company
Signature:Deepu Pylee
Name/Title:Compliance Director
Date:06/05/2026